Latin America Conference Attendees Gather Face-to-Face for First Time Since 2019
Erin JungmeyerAs LALCA 2023 gets under way in Montevideo, Uruguay, hear from chairs Drs. Luis Ubillos, Mario Varangot, Clarissa Mathias, and Carlos Barrios about the science that will be discussed. Read more
Despite Evidence of Benefit, Developing Countries Often Lack Routine Lung Cancer Screening Practices
Ricardo Sales dos Santos, MD, PhDExpert panel to discuss challenges and opportunities for increasing LDCT screening in Latin America during LALCA 2023. Read more
Presidential Symposium Features Best of Abstract Submissions
Luis E. Raez, MD+more
Highlighted studies explore the association of TP53 mutations with inferior prognosis in NSCLC patients of African ancestry, the possibilities for next-generation sequencing to guide therapy, and the use of a 12-gene expression panel to predict treatment benefit. Read more
China approves mobocertinib for patients with EGFR Exon20 insertion+ NSCLC; Deadline approaching for IASLC 2023 Lectureship and Distinguished Service Award Nominations. Read more
Dr. Emily Stone will succeed JTO Clinical and Research Reports founding editor Dr. Alex A. Adjei, who will remain editor-in-chief of the Journal of Thoracic Oncology. Read more
Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines
Nick IppolitoIn part 3 of our series on palliative and supportive care, Prof. Sun-Hyun Kim discusses the need for non-Western perspectives in recommendations for advanced care planning. Read more
Lecturer Reviews Patient Autonomy Law, its Impacts on End-of-Life Care
Nick IppolitoWrapping up our series on palliative and supportive care, Dr. Chih-Yuan Shih of National Taiwan University Hospital shares how protecting patients’ rights coupled with home-based palliative care improve end-of-life care. Read more
Long-time editorial group members, Drs. Mary Jo Fidler, Witold Rzyman, and Suresh Senan bring disciplinary diversity to ILCN’s leadership. Read more
Japan greenlights durvalumab and tremelimumab in combination with chemotherapy; US approves companion diagnostic tool for certain TKIs and expands indications for pemetrexed injection. Read more